HPX and hemolytic-uremic syndrome: STEC-HUS patients in the acute phase had significantly lower plasma hemopexin levels compared to healthy controls with median (range) of 0.4 (0.01–1.2) g/L and 0.9 (0.2–1.3) g/L respectively (p < 0.0001, Figure 1B).